Search

Your search keyword '"Boeckx, Bram"' showing total 163 results

Search Constraints

Start Over You searched for: Author "Boeckx, Bram" Remove constraint Author: "Boeckx, Bram" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
163 results on '"Boeckx, Bram"'

Search Results

1. Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

2. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases

3. Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment.

4. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program

5. A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

6. Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

7. Publisher Correction: p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity

8. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study

9. PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma

10. Single‐cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma

11. Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndrome

13. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling

14. PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial

16. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study

17. Timing evolution of lobular breast cancer through phylogenetic analysis

19. Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation

20. TOP-328-YI Single-nucleus RNA sequencing of the liver identifies predictive markers to corticosteroid treatment in patients with severe alcohol-related hepatitis

21. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade

22. Comparison of the single-cell and single-nucleus hepatic myeloid landscape within decompensated cirrhosis patients

23. Abstract A004: Comparison of ctDNA detection in seven different types of body liquids from patients with metastatic breast cancer

24. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program

25. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade.

26. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases

29. Author Reply to Peer Reviews of Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma

30. Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure

31. PD1-negative CD45RA effector-memory CD8 T-cells are essential for response to checkpoint inhibition in advanced hepatocellular carcinoma

32. Respiratory Complex I Regulates Dendritic Cell Maturation in Explant Model of Human Tumor Immune Microenvironment

33. Single-cell profiling and zebrafish avatars revealLGALS1as immunomodulating target in glioblastoma

34. PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.

36. Data from Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

37. Data from Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer

38. Supplementary Figure S1 from Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

39. Supplementary Data from Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer

40. Supplementary Figure from Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer

41. Supplementary Table from Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer

42. Supplementary Table S1 from Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

43. Supplementary figure legends and the title and notes of supplementary tables from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

44. Supplementary Figure S4 from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

45. Supplementary Tables from Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer

46. Supplementary Table S2 from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

48. Supplementary Data from Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer

49. Supplementary Data from Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer

50. Abstract P5-05-06: ctDNA detection in seven different types of body liquids in patients with metastatic breast cancer

Catalog

Books, media, physical & digital resources